262 related articles for article (PubMed ID: 25629724)
1. ADAM8 as a drug target in pancreatic cancer.
Schlomann U; Koller G; Conrad C; Ferdous T; Golfi P; Garcia AM; Höfling S; Parsons M; Costa P; Soper R; Bossard M; Hagemann T; Roshani R; Sewald N; Ketchem RR; Moss ML; Rasmussen FH; Miller MA; Lauffenburger DA; Tuveson DA; Nimsky C; Bartsch JW
Nat Commun; 2015 Jan; 6():6175. PubMed ID: 25629724
[TBL] [Abstract][Full Text] [Related]
2. Propofol affects the growth and metastasis of pancreatic cancer via ADAM8.
Yu X; Shi J; Wang X; Zhang F
Pharmacol Rep; 2020 Apr; 72(2):418-426. PubMed ID: 32048249
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression.
Puolakkainen P; Koski A; Vainionpää S; Shen Z; Repo H; Kemppainen E; Mustonen H; Seppänen H
Med Oncol; 2014 Mar; 31(3):884. PubMed ID: 24526468
[TBL] [Abstract][Full Text] [Related]
4. Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells.
Awan T; Babendreyer A; Mahmood Alvi A; Düsterhöft S; Lambertz D; Bartsch JW; Liedtke C; Ludwig A
J Cell Mol Med; 2021 Feb; 25(4):1982-1999. PubMed ID: 33314720
[TBL] [Abstract][Full Text] [Related]
5. ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer.
Valkovskaya N; Kayed H; Felix K; Hartmann D; Giese NA; Osinsky SP; Friess H; Kleeff J
J Cell Mol Med; 2007; 11(5):1162-74. PubMed ID: 17979891
[TBL] [Abstract][Full Text] [Related]
6. ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance.
Conrad C; Benzel J; Dorzweiler K; Cook L; Schlomann U; Zarbock A; Slater EP; Nimsky C; Bartsch JW
Clin Sci (Lond); 2019 Jan; 133(1):83-99. PubMed ID: 30635388
[TBL] [Abstract][Full Text] [Related]
7. ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis.
Romagnoli M; Mineva ND; Polmear M; Conrad C; Srinivasan S; Loussouarn D; Barillé-Nion S; Georgakoudi I; Dagg Á; McDermott EW; Duffy MJ; McGowan PM; Schlomann U; Parsons M; Bartsch JW; Sonenshein GE
EMBO Mol Med; 2014 Feb; 6(2):278-94. PubMed ID: 24375628
[TBL] [Abstract][Full Text] [Related]
8. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
Begum A; Ewachiw T; Jung C; Huang A; Norberg KJ; Marchionni L; McMillan R; Penchev V; Rajeshkumar NV; Maitra A; Wood L; Wang C; Wolfgang C; DeJesus-Acosta A; Laheru D; Shapiro IM; Padval M; Pachter JA; Weaver DT; Rasheed ZA; Matsui W
PLoS One; 2017; 12(7):e0180181. PubMed ID: 28692661
[TBL] [Abstract][Full Text] [Related]
9. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
10. Propofol mediates pancreatic cancer cell activity through the repression of ADAM8 via SP1.
Gao Y; Zhou Y; Wang C; Sample KM; Yu X; Ben-David Y
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34617574
[TBL] [Abstract][Full Text] [Related]
11. ADAM8-Dependent Extracellular Signaling in the Tumor Microenvironment Involves Regulated Release of Lipocalin 2 and MMP-9.
Cook L; Sengelmann M; Winkler B; Nagl C; Koch S; Schlomann U; Slater EP; Miller MA; von Strandmann EP; Dörsam B; Preußer C; Bartsch JW
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216088
[TBL] [Abstract][Full Text] [Related]
12. ADAM8 localizes to extravillous trophoblasts within the maternal-fetal interface and potentiates trophoblast cell line migration through a β1 integrin-mediated mechanism.
Le HT; Atif J; Mara DL; Castellana B; Treissman J; Baltayeva J; Beristain AG
Mol Hum Reprod; 2018 Oct; 24(10):495-509. PubMed ID: 30124911
[TBL] [Abstract][Full Text] [Related]
13. A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.
Chen J; Deng L; Dreymüller D; Jiang X; Long J; Duan Y; Wang Y; Luo M; Lin F; Mao L; Müller B; Koller G; Bartsch JW
Sci Rep; 2016 Jul; 6():30451. PubMed ID: 27458083
[TBL] [Abstract][Full Text] [Related]
14. ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma.
Oria VO; Lopatta P; Schmitz T; Preca BT; Nyström A; Conrad C; Bartsch JW; Kulemann B; Hoeppner J; Maurer J; Bronsert P; Schilling O
Mol Oncol; 2019 Feb; 13(2):456-479. PubMed ID: 30556643
[TBL] [Abstract][Full Text] [Related]
15. Propofol inhibits pancreatic cancer proliferation and metastasis by up-regulating miR-328 and down-regulating ADAM8.
Yu X; Gao Y; Zhang F
Basic Clin Pharmacol Toxicol; 2019 Sep; 125(3):271-278. PubMed ID: 30861616
[TBL] [Abstract][Full Text] [Related]
16. Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion.
Jiang H; Liu X; Knolhoff BL; Hegde S; Lee KB; Jiang H; Fields RC; Pachter JA; Lim KH; DeNardo DG
Gut; 2020 Jan; 69(1):122-132. PubMed ID: 31076405
[TBL] [Abstract][Full Text] [Related]
17. TrkB/C-induced HOXC6 activation enhances the ADAM8-mediated metastasis of chemoresistant colon cancer cells.
Park GB; Choi S; Yoon YS; Kim D
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846772
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.
Tang D; Zhang J; Yuan Z; Gao J; Wang S; Ye N; Li P; Gao S; Miao Y; Wang D; Jiang K
PLoS One; 2014; 9(3):e90476. PubMed ID: 24595374
[TBL] [Abstract][Full Text] [Related]
19. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.
Zhao W; Ajani JA; Sushovan G; Ochi N; Hwang R; Hafley M; Johnson RL; Bresalier RS; Logsdon CD; Zhang Z; Song S
Gastroenterology; 2018 Apr; 154(5):1524-1537.e6. PubMed ID: 29274868
[TBL] [Abstract][Full Text] [Related]
20. Extracellular gamma-synuclein promotes tumor cell motility by activating β1 integrin-focal adhesion kinase signaling pathway and increasing matrix metalloproteinase-24, -2 protein secretion.
Liu C; Qu L; Zhao C; Shou C
J Exp Clin Cancer Res; 2018 Jun; 37(1):117. PubMed ID: 29903032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
